Newsletters and Deep Dive digital magazine
Eli Lilly has unveiled a new partnership with diabetes device maker Dexcom to breathe new life into its diabetes division.
A new deal with diabetes specialists Dexcom will let diabetes patients see continuous glucose monitor (CGM) data on Fitbit’s new Ionic smartwatch.
The FDA has approved the first insulin pump - glucose monitor combination of devices which can recommend treatment decisions without the need for a finger-prick blood test.
A round-up of this week's digital healthcare news. Marco Ricci reports.
In an industry growing as quickly as cell therapy, keeping up with the demands of manufacturing and treatment is a challenge for the whole industry to tackle together, including stakeholder
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho